These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3886998

  • 1. Results of a controlled drug trial in membranoproliferative glomerulonephritis.
    Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Rance PC, Ritchie SM, Corey PN.
    Kidney Int; 1985 Feb; 27(2):436-41. PubMed ID: 3886998
    [Abstract] [Full Text] [Related]

  • 2. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
    Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH.
    Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
    [Abstract] [Full Text] [Related]

  • 3. Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS).
    Zäuner I, Böhler J, Braun N, Grupp C, Heering P, Schollmeyer P.
    Nephrol Dial Transplant; 1994 Feb; 9(6):619-22. PubMed ID: 7970086
    [Abstract] [Full Text] [Related]

  • 4. Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis.
    Zimmerman SW, Moorthy AV, Dreher WH, Friedman A, Varanasi U.
    Am J Med; 1983 Dec; 75(6):920-7. PubMed ID: 6359877
    [Abstract] [Full Text] [Related]

  • 5. Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I.
    Harmankaya O, Baştürk T, Oztürk Y, Karabiber N, Obek A.
    Int Urol Nephrol; 2001 Dec; 33(3):583-7. PubMed ID: 12230299
    [Abstract] [Full Text] [Related]

  • 6. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
    Murphy BF, McDonald I, Fairley KF, Kincaid-Smith PS.
    Clin Nephrol; 1992 May; 37(5):229-34. PubMed ID: 1606772
    [Abstract] [Full Text] [Related]

  • 7. Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.
    Brown CB, Wilson D, Turner D, Cameron JS, Ogg CS, Chantler C, Gill D.
    Lancet; 1974 Nov 16; 2(7890):1166-72. PubMed ID: 4139590
    [No Abstract] [Full Text] [Related]

  • 8. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
    Shearman JD, Yin ZG, Aarons I, Smith PS, Woodroffe AJ, Clarkson AR.
    Clin Nephrol; 1988 Dec 16; 30(6):320-9. PubMed ID: 3243041
    [Abstract] [Full Text] [Related]

  • 9. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
    Donadio JV, Anderson CF, Mitchell JC, Holley KE, Ilstrup DM, Fuster V, Chesebro JH.
    N Engl J Med; 1984 May 31; 310(22):1421-6. PubMed ID: 6371535
    [Abstract] [Full Text] [Related]

  • 10. Poststreptococcal crescenteric glomerulonephritis in children: comparison of quintuple therapy versus supportive care.
    Roy S, Murphy WM, Arant BS.
    J Pediatr; 1981 Mar 31; 98(3):403-10. PubMed ID: 7205449
    [Abstract] [Full Text] [Related]

  • 11. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
    Kawasaki Y, Hosoya M, Takahashi A, Isome M, Tanji M, Suzuki H.
    Am J Kidney Dis; 2005 Mar 31; 45(3):510-8. PubMed ID: 15754273
    [Abstract] [Full Text] [Related]

  • 12. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM, Dimitrjević JZ, Nikolić VN, Ognjanović MV, Rodić BD, Slavković BV.
    Srp Arh Celok Lek; 1999 Mar 31; 127(5-6):163-71. PubMed ID: 10500423
    [Abstract] [Full Text] [Related]

  • 13. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
    Wu MJ, Shu KH, Chan LP, Lu YS, Cheng CH, Sheu SS, Hsu YH, Lian JD.
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan 31; 57(1):34-41. PubMed ID: 8820034
    [Abstract] [Full Text] [Related]

  • 14. Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation.
    Chapman SJ, Cameron JS, Chantler C, Turner D.
    Arch Dis Child; 1980 Jun 31; 55(6):446-51. PubMed ID: 7436483
    [Abstract] [Full Text] [Related]

  • 15. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
    Clin Nephrol; 1990 Sep 31; 34(3):103-7. PubMed ID: 2225560
    [Abstract] [Full Text] [Related]

  • 16. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM, Tareeva IE, Ivanov AA, Troepol'skaia OV, Krasnova TN, Varshavskiĭ VA, Proskurneva EP, Ivanova LV, Khudova IIu, Miroshnichenko NG.
    Ter Arkh; 2002 Sep 31; 74(6):11-8. PubMed ID: 12136475
    [Abstract] [Full Text] [Related]

  • 17. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS, Wong CF, Shawki H, Kapoor N, Pandya BK.
    Clin Nephrol; 2008 Apr 31; 69(4):298-301. PubMed ID: 18397706
    [Abstract] [Full Text] [Related]

  • 18. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
    Okuda Y, Ishikura K, Hamada R, Harada R, Sakai T, Hamasaki Y, Hataya H, Fukuzawa R, Ogata K, Honda M.
    Nephrology (Carlton); 2015 Apr 31; 20(4):286-92. PubMed ID: 25524631
    [Abstract] [Full Text] [Related]

  • 19. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
    Woo KT, Lee GS, Lau YK, Chiang GS, Lim CH.
    Clin Nephrol; 1991 Aug 31; 36(2):60-6. PubMed ID: 1934661
    [Abstract] [Full Text] [Related]

  • 20. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K, Matl I, Zabka J, Zástava V, Rossmann P, Prát V.
    Czech Med; 1985 Aug 31; 8(3):151-7. PubMed ID: 3932033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.